| ๅบๅ็ป็ - ๅธๅบๅๅ
ฅ- ่พฝๅฎๅบๅ | Roche | Shenyang, China | 2026-07-08 |
| ๆฃ่
่งฃๅณๆนๆก็ป็_่กๆถฒ | Roche | Nanjing, China | 2026-07-08 |
| ๅบๅ็ป็ - ๅธๅบๅๅ
ฅ- ๆตๆฑๅบๅ | Roche | Hangzhou, China | 2026-07-08 |
| Associate Manager - GMP/ GMPๅฏ็ป็ | Roche | Shanghai, China | 2026-07-08 |
| Head of MSAT Technology Transfer | Roche | Shanghai, China | 2026-07-08 |
| System Shaping Partner | Roche | Bratislava, Slovakia | 2026-07-08 |
| Customer Excellence & Digital Transformation Partner | Roche | Sant Cugat del Vallรจs, Spain | 2026-07-08 |
| Head of Health Economics and Outcomes | Roche | Switzerland | 2026-07-08 |
| ๅๆฐๆธ ้้ซ็บงๅๅ
ฅ็ญ็ฅ็ป็ | Roche | Shanghai, China | 2026-07-08 |
| RA Senior Director | Roche | Switzerland | 2026-07-08 |
| Chief of Staff | Roche | Tokyo, Japan | 2026-07-08 |
| Patient Safety Partner | Roche | Hong Kong, Hong Kong | 2026-07-08 |
| (ๅฏ๏ผๅคงๅฎขๆท็ป็ - MCE | Roche | Hangzhou, China | 2026-07-08 |
| ๏ผ้ซ็บง๏ผๆธ ้ๆๅฑ็ญ็ฅ็ป็ | Roche | Switzerland | 2026-07-08 |
| Customer Partner | Roche | Petaling Jaya, Malaysia | 2026-07-08 |
| Senior Safety Director | Roche | Mississauga, Canada | 2026-07-08 |
| Disease Level Partner - South Central UK | Roche | United Kingdom | 2026-07-08 |
| Analytics and Insights Lead - Partnering | Roche | Switzerland | 2026-07-08 |
| Patient Journey Partner, Oncology (Sumatra) | Roche | Medan, Indonesia | 2026-07-08 |
| Director/Associate Director of Safety, Facilities, and Security | Roche | Seattle, United States | 2026-07-08 |
| ๆฒป็้ขๅ็ป็ - ็ผ็งๆฒป็้ขๅ๏ผๅ
ฐๅท๏ผ | Roche | Switzerland | 2026-07-08 |
| Patient Journey Partner - Islamabad | Roche | Islamabad, Pakistan | 2026-07-08 |
| ๆฒป็้ขๅ็ป็ - ๅ
็ซๆฒป็้ขๅ - ๅฆ้จ | Roche | Xiamen, China | 2026-07-08 |
| ๆฒป็้ขๅ็ป็ - ๅ
็ซๆฒป็้ขๅ --ๅๆ | Roche | Nanchang, China | 2026-07-08 |
| ๆฃ่
่งฃๅณๆนๆก็ป็ - ๅ
็ซๆฒป็้ขๅ - ๆญฆๆฑ | Roche | Wuhan, China | 2026-07-08 |
| Customer Partner | Roche | Petaling Jaya, Malaysia | 2026-07-08 |
| Patient Journey Partner - Immune Ecosystem | Roche | Taipei, Taiwan | 2026-07-08 |
| Head of MSAT Qualification & Validation | Roche | Shanghai, China | 2026-07-08 |
| ๆฒป็้ขๅ็ป็ - ๆถๅ้่ฟ็คๆฒป็้ขๅ | Roche | Beijing, China | 2026-07-08 |
| (้ซ็บง๏ผไบงๅ็ป็-่บ็ๆฒป็้ขๅ | Roche | Shanghai, China | 2026-07-08 |
| (้ซ็บง๏ผไบงๅ็ป็-ไนณ่
บๆฒป็้ขๅ | Roche | Shanghai, China | 2026-07-08 |
| (้ซ็บง๏ผไบงๅ็ป็-ไนณ่
บๆฒป็้ขๅ | Roche | Shanghai, China | 2026-07-08 |
| FMI - Chef de Produit Diagnostics & Solutions de Sรฉquenรงage (d/f/m) | Roche | Meylan, France | 2026-07-08 |
| ๏ผๅฏ๏ผๅบๅ็ป็ - ๅธๅบๅๅ
ฅ- ไธๆตทๅบๅ | Roche | Shanghai, China | 2026-07-08 |
| ๆฒป็้ขๅ็ป็ - ไนณ่
บๆฒป็้ขๅ - ๅๆ | Roche | Nanchang, China | 2026-07-08 |
| ๅฎขๆท็ป็ - ๅๅญ่ฏๆญไปชๅจไธๆตๅบ - ็ง็ ๅธๅบ | Roche | Beijing, China | 2026-07-08 |
| Subchapter Lead, Head of Pathology | Roche | Tucson, United States | 2026-07-08 |
| ๏ผ้ซ็บง๏ผๆธ ้้ฃๆง็ป็ | Roche | Shanghai, China | 2026-07-08 |
| ๅฏ็ป็๏ผๆธ ้ไพๅบ | Roche | Shanghai, China | 2026-07-08 |
| Head of RIS Solution Selling | Roche | Switzerland | 2026-07-08 |
| ๆฒป็้ขๅ็ป็ - ไนณ่
บๆฒป็้ขๅ - ๆญๅท | Roche | Hangzhou, China | 2026-07-08 |
| ๆฒป็้ขๅ็ป็ - ็ผ็งๆฒป็้ขๅ - ็ฆๅท | Roche | Fuzhou, China | 2026-07-08 |
| ๆฒป็้ขๅ็ป็ - ๅ
็ซๆฒป็้ขๅ - ๅๆ | Roche | Nanchang, China | 2026-07-08 |
| Senior Partner Systems Delivery Expert - EPIE | Roche | Switzerland | 2026-07-08 |
| Patient Journey Partner Westรถsterreich (w/m/d) | Roche | Austria | 2026-07-08 |
| Head of RIS Market Adoption | Roche | Switzerland | 2026-07-08 |
| ๅบๅ็ญ็ฅๅ้กน็ฎ็ป็ - ไธๆตท | Roche | Shanghai, China | 2026-07-08 |
| ๅป้ขๆ็ฅๅๅๅ
ฅ๏ผ้ซ็บง๏ผ็ป็ | Roche | Shanghai, China | 2026-07-08 |
| Strategic Operating Model Partner | Roche | Basel, Switzerland | 2026-07-08 |
| ๏ผ้ซ็บง๏ผๆธ ้ๆๅฑ้กน็ฎ็ป็-ๅป้ข-ๅฑฑไธ | Roche | Switzerland | 2026-07-08 |